Sangamo Therapeutics (SGMOQ) EBT Margin Growth (3y) (2013 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) EBT Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | -77,617.00 |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 4.49 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 28,548.00 |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | 146,420.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -2.39 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 119,010.00 |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | 515.00 |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 1,380.00 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -7,697.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -7,697.00 |
| Sep 30, 2025 | -583,898.00 |
| Jun 30, 2025 | 3,765.00 |
| Mar 31, 2025 | -31,791.00 |
| Dec 31, 2024 | -23,229.00 |
| Sep 30, 2024 | 18,843.00 |
| Jun 30, 2024 | -995,836.00 |
| Mar 31, 2024 | -1.00 Mn |
| Dec 31, 2023 | -280,883.00 |
| Sep 30, 2023 | -109,264.00 |
| Jun 30, 2023 | -160,007.00 |
| Mar 31, 2023 | 34,215.00 |
| Sep 30, 2022 | 924.00 |
| Jun 30, 2022 | 13,655.00 |
| Mar 31, 2022 | 36,733.00 |
| Dec 31, 2021 | -6,261.00 |
| Sep 30, 2021 | -11,215.00 |
| Jun 30, 2021 | -9,147.00 |
| Mar 31, 2021 | -687.00 |
| Dec 31, 2020 | -5,713.00 |